ClinicaliQ Trial Snapshot
- Vercise™ DBS Dystonia Prospective Study — Recruiting • NCT02686125.
- Boston Scientific's Vercise deep brain stimulation improves dystonia symptoms in real-world clinical practice.
Verify eligibility, endpoints and current status on the original ClinicalTrials.gov registry before acting on this summary.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
To compile characteristics of real-world outcomes of Boston Scientific Corporation's commercially approved VerciseTM Deep Brain Stimulation (DBS) Systems for the treatment of dystonia. Conditions: Dystonia Interventions: Deep Brain Stimulation (DBS) Lead Sponsor: Boston Scientific Corporation Planned Enrollment: 300 participants